Ann: Becoming a Substantial Holder from AEF, page-29

"I stated earlier on that there is something fishy going on."

I don't think there is. Biotechs need money, money, money.

Whilst the dilution is big, we need cash to develop the potential.

As for Imugene being full of hot air. I don't believe that either. Just look at the directors, and the quality of their scientific boards. The head of ESMO is only on one in the world, Imugenes!

And CF33 did kill all of the 60 cancer cell lines tested against.

If you don't believe in imu (or ptx) that's fair enough. I actually think imu will do a deal or be taken over during the next six months, attracting a deal the likes that the asx biotechs have never seen. That could do wonders for the ptx sp and the biotech sector as a whole.